DWS Healthy Living NC
DE0009769851
DWS Healthy Living NC/ DE0009769851 /
NAV25/09/2024 |
Var.+1.7700 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
366.9500EUR |
+0.48% |
reinvestment |
Equity
Worldwide
|
DWS Investment GmbH ▶ |
Investment strategy
The fund is actively managed. The fund is not managed in reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector. The objective of the investment policy is to generate long-term capital appreciation.
To achieve this, the fund invests at least 85% of its assets in shares of the MFC share class of DWS Invest ESG Healthy Living (master fund). The objective of the investment policy of DWS Invest ESG Healthy Living is to generate above-average appreciation. To achieve this objective, the fund invests predominantly in equity securities of companies in the health care and consumer health care sector. Companies that have tied up at least half of their assets in this area or generate a significant proportion, i.e., at least half, of their revenues or net income in this area are attributed to the health care or consumer health care sector. The health care sector comprises the following segments: pharmaceuticals, biotechnology, medical technology, medical devices and medical consumer goods, health care services and technology, and managed care and life science systems.
Investment goal
The fund is actively managed. The fund is not managed in reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector. The objective of the investment policy is to generate long-term capital appreciation.
Dati master
Type of yield: |
reinvestment |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
- |
Business year start: |
01/01 |
Ultima distribuzione: |
02/01/2018 |
Banca depositaria: |
State Street Bank International GmbH |
Domicilio del fondo: |
Germany |
Permesso di distribuzione: |
Germany, Switzerland, Czech Republic |
Gestore del fondo: |
Schweers, Oliver |
Volume del fondo: |
324.79 mill.
EUR
|
Data di lancio: |
10/11/1997 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
0.00% |
Tassa amministrativa massima: |
1.50% |
Investimento minimo: |
0.00 EUR |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
DWS Investment GmbH |
Indirizzo: |
Mainzer Landstraße 11-17, 60329, Frankfurt am Main |
Paese: |
Germany |
Internet: |
www.dws.de
|
Attività
Mutual Funds |
|
99.10% |
Cash |
|
0.90% |
Filiali
Healthcare |
|
99.10% |
Cash |
|
0.90% |